INTERACTIONS BETWEEN HEAVY-METAL CHELATORS AND BOTULINUM NEUROTOXINS AT THE MOUSE NEUROMUSCULAR-JUNCTION

被引:23
作者
SHERIDAN, RE
DESHPANDE, SS
机构
[1] Neurotoxicology Branch, Pathophysiology Division U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground
关键词
D O I
10.1016/0041-0101(94)00185-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposure of isolated mouse hemidiaphragms to botulinum neurotoxins, 0.1 nM BoNT-A or BoNT-B, at 36 degrees C reduced nerve-elicited peak isometric twitch tension to 50% of control values at 55 min (BoNT-A) to 68 min (BoNT-B) after application, Either coincubation of BoNT with the heavy metal chelator TPEN, preincubation with TPEN followed by BoNT, or application of TPEN after BoNT but before neuromuscular block, delayed the onset of muscle failure in a dose-dependent manner by up to five-fold, TPEN doses between 2 and 10 mu M were required to antagonize significantly the muscle block produced by BoNT, and the delay in onset was maximal between 10 and 50 mu M TPEN. Treatment of muscles with a Zn2+-TPEN coordination complex, rather than TPEN alone, eliminated any beneficial effects of TPEN on BoNT intoxication, indicating that these effects were mediated by chelation of Zn2+. Other metal chelators that were not as membrane permeant as TPEN were ineffective in delaying BoNT paralysis, suggesting that TPEN acts by chelating intraterminal Zn2+. In the absence of BoNT, TPEN caused a dose-dependent increase in nerve-elicited twitch tension with a half-maximal concentration at 8 mu M. There was no corresponding change in twitches from direct electrical stimulation of the muscle. After BoNT (A or B serotype) had reduced the muscle twitch by 20 to 70%, however, subsequent application of TPEN rapidly depressed nerve-elicited twitches. The shift from potentiation to depression after BoNT treatment suggests that presynaptic vesicle mobilization and/or release involve Zn2+-dependent enzymes and that BoNTs interact with these enzyme pathways.
引用
收藏
页码:539 / 549
页数:11
相关论文
共 19 条
  • [1] ARSLAN P, 1985, J BIOL CHEM, V260, P2719
  • [2] BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25
    BLASI, J
    CHAPMAN, ER
    LINK, E
    BINZ, T
    YAMASAKI, S
    DECAMILLI, P
    SUDHOF, TC
    NIEMANN, H
    JAHN, R
    [J]. NATURE, 1993, 365 (6442) : 160 - 163
  • [3] KURAZONO H, 1992, J BIOL CHEM, V267, P14721
  • [4] MOLGO J, 1990, J PHYSIOLOGY PARIS, V84, P152
  • [5] ZINC SELECTIVELY BLOCKS THE ACTION OF N-METHYL-D-ASPARTATE ON CORTICAL-NEURONS
    PETERS, S
    KOH, J
    CHOI, DW
    [J]. SCIENCE, 1987, 236 (4801) : 589 - 593
  • [6] INHIBITION OF TRANSMITTER RELEASE BY BOTULINUM NEUROTOXIN-A - CONTRIBUTION OF VARIOUS FRAGMENTS TO THE INTOXICATION PROCESS
    POULAIN, B
    WADSWORTH, JDF
    MAISEY, EA
    SHONE, CC
    MELLING, J
    TAUC, L
    DOLLY, JO
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 185 (01): : 197 - 203
  • [7] TETANUS AND BOTULINUM-B NEUROTOXINS BLOCK NEUROTRANSMITTER RELEASE BY PROTEOLYTIC CLEAVAGE OF SYNAPTOBREVIN
    SCHIAVO, G
    BENFENATI, F
    POULAIN, B
    ROSSETTO, O
    DELAURETO, PP
    DASGUPTA, BR
    MONTECUCCO, C
    [J]. NATURE, 1992, 359 (6398) : 832 - 835
  • [8] TETANUS TOXIN IS A ZINC PROTEIN AND ITS INHIBITION OF NEUROTRANSMITTER RELEASE AND PROTEASE ACTIVITY DEPEND ON ZINC
    SCHIAVO, G
    POULAIN, B
    ROSSETTO, O
    BENFENATI, F
    TAUC, L
    MONTECUCCO, C
    [J]. EMBO JOURNAL, 1992, 11 (10) : 3577 - 3583
  • [9] THE PHARMACOLOGICAL MECHANISM OF BOTULISM
    SELLIN, LC
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (02) : 80 - 82
  • [10] EFFECT OF 3,4-DIAMINOPYRIDINE ON THE SURVIVAL OF MICE INJECTED WITH BOTULINUM NEUROTOXIN TYPE-A, TYPE-B, TYPE-E, OR TYPE-F
    SIEGEL, LS
    JOHNSONWINEGAR, AD
    SELLIN, LC
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1986, 84 (02) : 255 - 263